RICK (NT) Blocking Peptide

Home/Control Peptides/RICK (NT) Blocking Peptide

Pricing & Details

Product No.R1007
Protein
RICK
Formats AvailableView All
Product Type
Blocking Peptide
Alternate Names
RIP2, CARDIAK
Prod No.
Size
Price
Avail.
Qty
Add to cart
R1007-50 µg
50 µg
$110.00
In stock
Max:
Min: 1
Step: 1
Contact Us For Academic mAb Advantage Pricing

Antibody Details

Product Details

Reactivity Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
This peptide sequence is located at amino acids 11 to 30 of Human RICK protein.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Amino Acid Sequence
20 amino amino terminus of human RICK.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Background
RIP-Like Interacting CLARP Kinase peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

Antigen Details

Protein
PubMed

References & Citations

1. Zamzami N, Kroemer G. Condensed matter in cell death. Nature 1999;401:127-8 2. Yasuda T, Takeshita H, Iida R, Nakajima T, Hosomi O, Nakashima Y, Kishi K. Molecular cloning of the cDNA encoding human deoxyribonuclease II. J Biol Chem 1998;273:2610-6 3. Krieser RJ, Eastman A. The cloning and expression of human deoxyribonuclease II. A possible role in apoptosis. J Biol Chem 1998;273:30909-14 4. Shiokawa D, Tanuma S. Cloning of cDNAs encoding porcine and human DNase II. Biochem Biophys Res Commun 1998;247:864-9
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok